Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease ...
An update from Arcturus Therapeutics ( (ARCT)) is now available. On December 11, 2025, Arcturus Therapeutics announced the amicable departure of its Chief Financial Officer, Andy Sassine, effective ...
The Japanese drugs giant Takeda and the US biotech Arcturus Therapeutics have joined the hunt for therapies for the COVID-19 coronavirus. As the infection and death count continues to rise across the ...
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) announced changes to its executive leadership and board on Thursday. According to a statement based on a recent SEC filing, Andy Sassine, Chief ...
AAA fielded 8.1 million roadside calls last winter—the second-highest seasonal total of the year. When storms hit, that ...
Schubert Jonckheer & Kolbe LLP is investigating a data breach that led to unauthorized access to the sensitive information of 377,082 customers of Gulshan Management Services, a Texas-based business ...
Surf Air Mobility Inc. ("Surf Air Mobility"), a leading air mobility platform, today announced that Deanna White, CEO of Surf Air Mobility, will be in attendance and host virtual meetings at the 28th ...
Experts share with us their top survival tips if you’re stranded on the road or on the trail during treacherous winter storms ...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Kostaive (zapomeran) mRNA COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results